Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.06.2018 | Clinical study

Antipsychotics in youths: metabolic effects

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Youths with nonpsychotic disruptive behavioural disorders who receive off-label treatment with antipsychotics may develop adverse metabolic effects, according to study results reported in JAMA Psychiatry. …
Fußnoten
1
NCT00205699
 
Literatur
1.
Zurück zum Zitat Nicol GE, et al. Metabolic Effects of Antipsychotics on Adiposity and Insulin Sensitivity in Youths: A Randomized Clinical Trial. JAMA Psychiatry : 13 Jun 2018. Available from: URL: http://doi.org/10.1001/jamapsychiatry.2018.1088. Nicol GE, et al. Metabolic Effects of Antipsychotics on Adiposity and Insulin Sensitivity in Youths: A Randomized Clinical Trial. JAMA Psychiatry : 13 Jun 2018. Available from: URL: http://​doi.​org/​10.​1001/​jamapsychiatry.​2018.​1088.​
2.
Zurück zum Zitat De Hert M, et al. The Urgent Need for Optimal Monitoring of Metabolic Adverse Effects in Children and Youngsters Who Take On-label or Off-label Antipsychotic Medication. JAMA Psychiatry : 13 Jun 2018. Available from: URL: http://dx.doi.org/10.1001/jamapsychiatry.2018.1080. De Hert M, et al. The Urgent Need for Optimal Monitoring of Metabolic Adverse Effects in Children and Youngsters Who Take On-label or Off-label Antipsychotic Medication. JAMA Psychiatry : 13 Jun 2018. Available from: URL: http://​dx.​doi.​org/​10.​1001/​jamapsychiatry.​2018.​1080.​
Metadaten
Titel
Antipsychotics in youths: metabolic effects
Publikationsdatum
01.06.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-48096-9

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Nivolumab

Case report

Multiple drugs

Case report

Levamisole